Why You Might Still Be Eating on Wegovy — and What to Do About It

What the trial data actually show about appetite on semaglutide

The STEP 1 trial enrolled over 1,900 adults with obesity and tracked them for 68 weeks on semaglutide 2.4mg. The headline result (roughly 15% average weight loss) tells you about outcomes, not the week-by-week experience of eating. What the data also show is that the titration schedule matters. Participants started at 0.25mg and stepped up every four weeks; appetite suppression typically became more noticeable as the dose climbed. Expecting strong appetite changes at 0.25mg or 0.5mg sets up a false comparison.

Semaglutide works as a GLP-1 receptor agonist, it mimics a gut hormone that signals fullness to the brain and slows how quickly food leaves the stomach. That mechanism takes time to accumulate effect, and the brain's appetite circuits don't reset overnight. Some people describe a gradual shift: meals that used to feel too small start feeling like enough. Others need to reach a higher dose before that shift becomes obvious.

The practical takeaway: if you're still eating your usual amounts in the first month or two, that's within the documented range. The question worth asking is whether anything has shifted, portion sizes, fullness signals, the urge to snack late in the evening. A useful one-minute habit: before sitting down to eat, pause and rate your actual hunger on a simple 1–10 scale. Over a few weeks, a pattern often emerges that's more informative than day-to-day variation.

Why some people feel less appetite suppression than others

Appetite response to Wegovy isn't uniform. Several factors influence how strongly the medicine affects hunger. Dose is the most obvious, the full appetite-suppressing effect is generally associated with the maintenance doses (2.4mg, or 7.2mg for those on the higher-dose pen approved in 2026), not the starter steps. If you're still in the titration phase, that context matters.

Food composition plays a role too. High-fat, high-sugar foods empty from the stomach faster than protein and fibre-rich meals, which can blunt the fullness signal Wegovy is trying to amplify. Someone eating mainly processed foods may genuinely feel less satisfied than someone whose meals are built around lean protein and vegetables, not because the medicine is failing, but because the dietary environment is working against it. Our guide to what to eat on Wegovy covers this in detail.

Stress, poor sleep and emotional eating patterns can also override the medicine's signals. GLP-1 agonists reduce physiological hunger; they don't directly alter the habitual or emotional drive to eat. If you recognise that you're eating when you're not physically hungry, that's worth exploring separately, and your prescriber can help you think through it. Medication is one tool; the lifestyle context around it shapes what that tool can do.

When persistent appetite is worth a clinical conversation

There's a meaningful difference between still eating normal amounts during the titration phase and feeling unchanged hunger at a stable maintenance dose after several months. The former is expected. The latter is a reasonable prompt for a review.

Your prescriber may want to look at a few things: whether the dose is genuinely at the maintenance level for you, whether anything has changed in your wider health picture, and whether your dietary pattern is supporting the medicine's effect. An eating plan built around Wegovy (higher protein, adequate fibre, consistent meal timing) can make a real difference to how effectively the medicine's appetite signals translate into lower overall intake.

It's also worth knowing that some people experience a period of what's sometimes called a weight-loss plateau, where the scales stop moving even though nothing obvious has changed. That's not always about appetite; it can reflect metabolic adaptation. The NHS England guidance on weight-management injections is clear that these medicines work best as part of a broader approach that includes dietary support, not as a standalone fix.

If you're unsure whether what you're experiencing is typical or worth discussing, our page on still feeling hungry on Wegovy covers some of the specific scenarios in more depth. Questions about cost and continuing treatment are addressed on our Wegovy cost page.

For a full picture of how Wegovy works and what to expect across the treatment period, the Wegovy treatment overview is a good starting point. And if you're at the stage of thinking about whether this is the right medicine for you, our prescribers are here to help you work that out, and you can also read our practical guidance on eating on Wegovy before your consultation. Speak to our prescribers through a free consultation.